KPRP Inhibitors
Chemical inhibitors of KPRP can act through various mechanisms to hinder its function, primarily targeting the phosphorylation processes that are crucial for KPRP's activity. Alsterpaullone, as a cyclin-dependent kinase (CDK) inhibitor, can prevent the phosphorylation events necessary for KPRP's function, leading to its functional inhibition. Similarly, Roscovitine and Olomoucine, both selective CDK inhibitors, can suppress KPRP activity by blocking the phosphorylation that KPRP requires for activation. Purvalanol A, another potent CDK inhibitor, can inhibit KPRP by preventing the phosphorylation it necessitates for optimal function. Indirubin-3'-monoxime, by inhibiting CDKs, can decrease KPRP function if it relies on CDK-mediated activation or stability. 5-Iodotubercidin, an adenosine kinase inhibitor, can reduce the overall phosphorylation status of KPRP if its activity is contingent upon such modification.
Continuing with this approach, AZD5438 inhibits CDK1, CDK2, and CDK9, which can lead to the functional inhibition of KPRP if its activity is dependent on these kinases. Ribociclib, by inhibiting CDK4 and CDK6, can impede KPRP function if KPRP activation or stability is regulated by CDK4/6-mediated phosphorylation. PD 0332991, with a similar mechanism of CDK4/6 inhibition, can also result in reduced KPRP function. Flavopiridol, which inhibits several CDKs, can also functionally inhibit KPRP if it is dependent on phosphorylation by these kinases. Dinaciclib, known for robust CDK inhibition, can suppress KPRP activity if it relies on phosphorylation by these CDKs.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor, which may impede the phosphorylation events required for the functional activity of KPRP, leading to its inhibition as phosphorylation is often critical for protein function. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine selectively inhibits CDKs, which could result in the suppression of KPRP activity if phosphorylation by CDKs is necessary for KPRP's function. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Olomoucine is another CDK inhibitor that can prevent the phosphorylation of proteins involved in cell cycle regulation; if KPRP's activity is reliant on such phosphorylation, its function would be inhibited as a result. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
Purvalanol A, a CDK inhibitor, may inhibit KPRP by blocking the phosphorylation it requires for proper function, assuming KPRP is a phosphorylation-dependent protein. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is known to inhibit CDKs; if KPRP requires CDKs for its activation or stability, this inhibition would result in decreased KPRP function. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin is an adenosine kinase inhibitor which could reduce the phosphorylation status of various proteins. If KPRP function is contingent upon this phosphorylation, its activity will be hindered. | ||||||
AZD 5438 | 602306-29-6 | sc-361115 sc-361115A | 10 mg 50 mg | $205.00 $865.00 | ||
AZD5438 inhibits CDK1, CDK2, and CDK9 which could lead to functional inhibition of KPRP if its activity is dependent on the kinase activity of these CDKs. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Ribociclib inhibits CDK4 and CDK6; should KPRP activity be regulated by CDK4/6-mediated phosphorylation, inhibition by Ribociclib would result in reduced KPRP function. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor and could impede KPRP function if KPRP relies on CDK4/6 for its activation or stability through phosphorylation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits several CDKs and if KPRP activity is dependent on phosphorylation by these kinases, flavopiridol would functionally inhibit KPRP. | ||||||